The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma—differences in histological subtypes

BACKGROUND: Extensive research has increased our understanding of the molecular alterations needed for non-small cell lung cancer (NSCLC) development. Deregulation of a pathway including MYCN, HMGA2 and CDKN2A, with the participation of DICER1, is of importance in several solid tumours, and may also...

Descripción completa

Detalles Bibliográficos
Autores principales: Eide, Hanne A., Halvorsen, Ann Rita, Bjaanæs, Maria Moksnes, Piri, Hossein, Holm, Ruth, Solberg, Steinar, Jørgensen, Lars, Brustugun, Odd Terje, Kiserud, Cecilie Essholt, Helland, Åslaug
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746877/
https://www.ncbi.nlm.nih.gov/pubmed/26858029
http://dx.doi.org/10.1186/s12885-016-2104-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746877/
https://www.ncbi.nlm.nih.gov/pubmed/26858029
http://dx.doi.org/10.1186/s12885-016-2104-9

Ejemplares similares